Similar to the Ahmed et al. study, concordant variants had large effects on cardiometabolic disease and an increase in liver-related outcomes, while the discordant group (dominated by PNPLA3 and TM6SF2 variants) had larger effects on HCC and cirrhosis but no effect or even protection from CVD (105). The gene discussed is TM6SF2; the disease is Cirrhosis.